Deregulated NF-κB activity plays a critical role in the survival and radiation resistance of tumor cells in a variety of human neoplasias including B cell lymphomas (BCLs) [1-5]. This evidence concerns the gene NFKB1 and B-cell non-Hodgkin lymphoma.